Prothea Technologies

👥 12 employees💰 Last funded Jan 2024
Prothea Technologies is a private medical technology company with a vision to offer lung cancer biopsy and treatment in a single hospital visit. Lung cancer is the third most common form of cancer in the U.S. and annually claims more lives than breast, prostate and colon cancer combined.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
1
Frequently asked questions
Who invested in Prothea Technologies?
Prothea Technologies has 1 investors on record on gritt.io.
When did Prothea Technologies last raise funding?
The most recent investment in Prothea Technologies recorded on gritt.io was in January 2024.
What industry is Prothea Technologies in?
Prothea Technologies operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.